New Drug Acceptance News Today : Breaking News, Live Updates & Top Stories | Vimarsana

New analyses from the phase 3 MAESTRO-NASH support the oral daily drug's benefit for cardiovascular and hormonal outcomes over 1 year.

United statesStephena harrisonNaim alkhouriBecky taubPinnacle clinical researchMadrigal pharmaceuticalsDrug administrationFatty liver program at arizona healthMadrigal pharmaceuticals announcesLiver meetingAmerican associationLiver diseasesNew drug acceptanceTransplant hepatologyFatty liver programArizona liver health